Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN^® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

B. W. Bode, J. B. Buse, M. Fisher, S. K. Garg, M. Marre, L. Merker, E. Renard, D. L. Russell-Jones, C. T. Hansen, A. Rana and S. R. Heller

Diabetic Medicine 30 ( 11 ): 1293 - 1297 , 2013